Clinical trial
Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal…
NCT00012051 · Commissie Voor Klinisch Toegepast Onderzoek, Other · Completed
Key facts
| NCT number | NCT00012051 |
|---|---|
| Title | Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma |
| Official title | A Randomised Phase III Study On The Effect Of The Chimeric Anti-CD20 Monoclonal Antibody (Mabthera) During Sequential Chemotherapy Followed By Autologous Stem Cell Transplantation In Patients With Relapse B-Cell Non-Hodgkin Lymphoma(HOVON 44 STUDY) |
| Lead sponsor | Commissie Voor Klinisch Toegepast Onderzoek, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, rituximab, carmustine, cisplatin, cytarabine, dexamethasone, etoposide, ifosfamide, melphalan, methotrexate and 3 more |
| Enrollment | 340 |
| Start date | Sep 1, 2000 |
| Completion | Oct 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 12, 2013 |
| Countries | Belgium, Netherlands |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: